Abstract:International Journal of Biomathematics, Ahead of Print. Drug–target interaction (DTI) is a widely explored topic in the field of bioinformatics and plays a pivotal role in drug discovery. However, the traditional bio-experimental process of drug–target interaction identification requires a large investment of time and labor. To address this challenge, graph neural network (GNN) approaches in deep learning are becoming a prominent trend in the field of DTI research, which is characterized by multimodal processing of data, feature learning and interpretability in DTI. Nevertheless, some methods are still limited by homogeneous graphs and single features. To address the problems, we mechanistically analyze graph convolutional neural networks (GCNs) and graph attentional neural networks (GATs) to propose a new model for the prediction of drug–target interactions using graph neural networks named BiTGNN [Bidirectional Transformer (Bi-Transformer)–graph neural network]. The method first establishes drug–target pairs through the pseudo-position specificity scoring matrix (PsePSSM) and drug fingerprint data, and constructs a heterogeneous network by utilizing the relationship between the drug and the target. Then, the computational extraction of drug and target attributes is performed using GCNs and GATs for the purpose of model information flow extension and graph information enhancement. We collect interaction data using the proposed Bi-Transformer architecture, in which we design a bidirectional cross-attention mechanism for calculating the effects of drug–target interactions for realistic biological interaction simulations. Finally, a feed-forward neural network is used to obtain the feature matrices of the drug and the target, and DTI prediction is performed by fusing the two feature matrices. The Enzyme, Ion Channel (IC), G Protein-coupled Receptor (GPCR) and Nuclear Receptor (NR) datasets are used in the experiments, and compared with several existing mainstream models, our model outperforms in Area Under the ROC Curve (AUC), Specificity, Accuracy and the metric Area Under the Precision–Recall Curve (AUPR).

IMAEN: An interpretable molecular augmentation model for drug–target interaction prediction

Effective drug-target interaction prediction with mutual interaction neural network

An Ensemble Learning-Based Method for Inferring Drug-Target Interactions Combining Protein Sequences and Drug Fingerprints

MGNDTI: A Drug-Target Interaction Prediction Framework Based on Multimodal Representation Learning and the Gating Mechanism

GSAML-DTA: An interpretable drug-target binding affinity prediction model based on graph neural networks with self-attention mechanism and mutual information

BiTGNN: Prediction of drug–target interactions based on bidirectional transformer and graph neural network on heterogeneous graph

GIFDTI: Prediction of Drug-Target Interactions Based on Global Molecular and Intermolecular Interaction Representation Learning.

Drug–Target Interaction Prediction Based on an Interactive Inference Network

Drug-Target Affinity Prediction Based on Improved GraphDTA

EmbedDTI: Enhancing the Molecular Representations via Sequence Embedding and Graph Convolutional Network for the Prediction of Drug-Target Interaction

CSDTI: an interpretable cross-attention network with GNN-based drug molecule aggregation for drug-target interaction prediction

Multidta: drug-target binding affinity prediction via representation learning and graph convolutional neural networks

ERT-GFAN: A multimodal drug-target interaction prediction model based on molecular biology and knowledge-enhanced attention mechanism

MINDG: A Drug-Target Interaction Prediction Method Based on an Integrated Learning Algorithm

KenDTI: An Ensemble Model for Predicting Drug-Target Interaction by Integrating Multi-Source Information

IMCHGAN: Inductive Matrix Completion With Heterogeneous Graph Attention Networks for Drug-Target Interactions Prediction

MSH-DTI: multi-graph convolution with self-supervised embedding and heterogeneous aggregation for drug-target interaction prediction

Predicting Molecule-Target Interaction by Learning Biomedical Network and Molecule Representations

AttentionMGT-DTA: A multi-modal drug-target affinity prediction using graph transformer and attention mechanism

HiGNN: Hierarchical Informative Graph Neural Networks for Molecular Property Prediction Equipped with Feature-Wise Attention

Drug-Target Binding Affinity Prediction by Combination Graph Neural Network and BiLSTM